Preformulation investigation of the novel proton pump inhibitor lansoprazole

Drug Development and Industrial Pharmacy

Volumn 26, Issue 7, 2000, Pages 781-783

  Kristl, Albin ^a   Vrečer, Franc ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b KRKA D D   (Slovenia)

Author keywords

Lansoprazole; Log P; Physicochemical properties; pK(a)

Indexed keywords

LANSOPRAZOLE; OCTANOL; PROTON PUMP INHIBITOR; WATER;

AQUEOUS SOLUTION; ARTICLE; DISSOLUTION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG INFORMATION; DRUG SOLUBILITY; PH; PHYSICAL CHEMISTRY; PREFORMULATION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; OMEPRAZOLE; PROTON PUMPS; SOLUBILITY;

EID: 0343963181     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100101299     Document Type: Article

References (4)

1. L. B. Barradell, D. Faulds, and D. McTavish, Lansoprazole, a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders, Drugs, 44, 225-250 (1992).
2. T. Tabata, T. Makino, T. Kashihara, S. Hirai, N. Kitamori, and H. Taguchi, Stabilisation of a new antiulcer drug (lansoprazole) in the solid dosage forms, Drug Dev. Ind. Pharm., 18, 1437-1447 (1992).
3. A. Albert, R. Goldrace, and J. Philips, The strength of heterocyclic bases, J. Chem. Soc., 70, 2240-2249 (1948).
4. T. Tabata, T. Makino, J. Kikuta, S. Hirai, and N. Kitamori, Manufacturing method of stable enteric granules of a new antiuleer drug (lansoprazole), Drug Dev. Ind. Pharm., 20, 1661-1672 (1994).